ArticleNature and science of sleep2026
Polysomnographic Characteristics and Sleep Disorders in Pediatric Moyamoya Arteriopathy.
Article in Nature and science of sleep, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to describe the polysomnographic characteristics and sleep-related symptoms in pediatric patients with Moyamoya arteriopathy (MMA) referred for sleep evaluation. Patients and Methods: We conducted a retrospective case series of pediatric patients with MMA who were referred to the sleep clinic at The Hospital for Sick Children, Toronto, Canada, and underwent level 1 polysomnography (PSG) between 2014 and 2024. Clinical, demographic, genetic, and sleep-related data, including PSG and multiple sleep latency test (MSLT) findings were reviewed. Results: Eleven pediatric patients were included, with a median (IQR) age of 15 (13, 17) years. Sleep fragmentation was commonly observed on PSG (n=10, 90.9%), while no patients demonstrated clinically significant sleep-disordered breathing. A trend toward shorter REM latency was noted compared with age-matched normative values. Daytime fatigue was the most frequently reported symptom (n=6, 54.5%). Two patients underwent MSLT due to persistent hypersomnolence; one met diagnostic criteria for narcolepsy. Conclusion: In this retrospective case series, sleep fragmentation and a trend toward shorter REM latency were commonly observed in pediatric patients with MMA. However, given the small sample size and absence of pre-revascularization baseline data, these findings should be interpreted with caution. These results are descriptive and hypothesis-generating, and further prospective studies are needed to better understand sleep disturbances in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.